MacroGenics, Inc. (MGNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

5.55

+0.05

(+0.91%)

At close: 04:00PM EDT

5.75

+0.20

(+3.60%)

After hours:

07:05PM EDT

Loading interactive chart…

Simply Wall St.
MacroGenics Insider Ups Holding By 83% During Year
Looking at MacroGenics, Inc.'s ( NASDAQ:MGNX ) insider transactions over the last year, we can see that insiders were...
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conference
ROCKVILLE, MD, June 11, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conference this month: Goldman Sachs 45th Annual Global Healthcare Conference (Miami Beach). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., P
Simply Wall St.
Shareholders in MacroGenics (NASDAQ:MGNX) are in the red if they invested three years ago
This month, we saw the MacroGenics, Inc. ( NASDAQ:MGNX ) up an impressive 37%. But that doesn't change the fact that...